Don’t miss the latest developments in business and finance.

Home / India News / Zydus Cadila receives final approval for Felbamate Tablets

Zydus Cadila receives final approval for Felbamate Tablets

Image
Capital Market
Last Updated : May 31 2017 | 7:01 PM IST
Connect with us
Facebook IconLinkedIN Icon

From USFDA

Zydus Cadila has received final approval from USFDA to market Felbamate Tablets USP in strengths of 400 mg and 600 mg.

Powered by Capital Market - Live News

Connect with us on WhatsApp

Also Read

Zydus Cadila receives final approval for Cyproheptadine Hydrochloride Tablets USP

Zydus receives final approval for Olmesartan Medoxomil Tablets

Zydus Cadila receives USFDA nod to market fluconazole tablets

Cadila Healthcare gains after receiving final approval for Methotrexate tablets

Alembic Pharmaceuticals receives final approval for Olmesartan Medoxomil Tablets & Medoxomil with Hydrochlorothiazide Tablets

First Published: May 31 2017 | 6:53 PM IST

Explore News

Next Story